Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery
Summary
The company will set a new standard of care for stroke recovery, accessible to patients and caregivers at home, with a first-in-kind end-to-end solution for stroke survivors, combining brain computer interface (BCI) technology with personalized telehealth services.As part of the merger, Kandu Inc. completed the first close of a $30 million financing, which was co-led by Ally Bridge Group and AMED Ventures, with participation from other existing investors. Neurolutions, founded in 2007, is the leader in the use of non-invasive BCI technology for post-stroke therapy.Kandu provides remote, multidisciplinary support to stroke survivors and care partners in outpatient settings through a team of licensed clinicians and an easy-to-use app. Neurolutions IpsiHand\xae System is the only noninvasive FDA-cleared breakthrough device that accelerates motor recovery of the affected upper limb after chronic stroke.By combining the infrastructure and technology of the two companies, Kandu, Inc. is uniquely positioned to provide a breadth of services that have historically been unavailable or inaccessible to stroke survivors: telehealth rehabilitation, therapy monitoring, education, caregiver support, advocacy and navigation. Kandu Health has demonstrated dramatically lower rates of hospital readmission and significantly improved functional outcomes in patients recovering from stroke in the home setting. Stroke survivors and caregivers often struggle with navigating the complex and disconnected healthcare system, leading to high hospital readmission rates and ongoing health challenges.